Candida albicans biofilms: Building a heterogeneous, drug-tolerant environment

Current Opinion in Microbiology

Volumn 16, Issue 4, 2013, Pages 398-403

  Bonhomme, Julie ^a   d'Enfert, Christophe ^b,c  

^a CHU CÔTE DE NACRE   (France)

^b INSTITUT PASTEUR   (France)

^c INRA F 75015   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 1,3 GLUCAN; FLUCONAZOLE; TRANSCRIPTION FACTOR;

AMINO ACID METABOLISM; BIOFILM; CANDIDA ALBICANS; EXTRACELLULAR MATRIX; FUNGAL GENE; GENE EXPRESSION; HOST PATHOGEN INTERACTION; MINIMUM INHIBITORY CONCENTRATION; MORPHOGENESIS; REVIEW; TRANSCRIPTION REGULATION;

CANDIDA ALBICANS; FUNGI;

ANTIFUNGAL AGENTS; BIOFILMS; CANDIDA ALBICANS; DRUG TOLERANCE;

EID: 84882833653     PISSN: 13695274     EISSN: 18790364     Source Type: Journal    
DOI: 10.1016/j.mib.2013.03.007     Document Type: Review

References (53)

1. Costerton J.W., Stewart P.S., Greenberg E.P. Bacterial biofilms: a common cause of persistent infections. Science 1999, 284:1318-1322.
2. Donlan R.M., Costerton J.W. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 2002, 15:167-193.
3. Hall-Stoodley L., Stoodley P. Evolving concepts in biofilm infections. Cell Microbiol 2009, 11:1034-1043.
4. Ning Y., Hu X., Ling J., Du Y., Liu J., Liu H., Peng Z. Candida albicans survival and biofilm formation under starvation conditions. Int Endod J 2013, 46:62-70.
5. Stoodley P., Sauer K., Davies D.G., Costerton J.W. Biofilms as complex differentiated communities. Annu Rev Microbiol 2002, 56:187-209.
6. Monroe D. Looking for chinks in the armor of bacterial biofilms. PLoS Biol 2007, 5:e307.
7. Chandra J., Kuhn D.M., Mukherjee P.K., Hoyer L.L., McCormick T., Ghannoum M.A. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J Bacteriol 2001, 183:5385-5394.
8. Mowat E., Williams C., Jones B., McChlery S., Ramage G. The characteristics of Aspergillus fumigatus mycetoma development: is this a biofilm?. Med Mycol 2009, 47(Suppl 1):S120-S126.
9. Kumamoto C.A. Candida biofilms. Curr Opin Microbiol 2002, 5:608-611.
10. Hawser S.P., Douglas L.J. Biofilm formation by Candida species on the surface of catheter materials in vitro. Infect Immun 1994, 62:915-921.
11. Blankenship J.R., Mitchell A.P. How to build a biofilm: a fungal perspective. Curr Opin Microbiol 2006, 9:588-594.
12. Finkel J.S., Mitchell A.P. Genetic control of Candida albicans biofilm development. Nat Rev Microbiol 2011, 9:109-118.
13. Nobile C.J., Mitchell A.P. Regulation of cell-surface genes and biofilm formation by the C. albicans transcription factor Bcr1p. Curr Biol 2005, 15:1150-1155.
14. Ramage G., VandeWalle K., Lopez-Ribot J.L., Wickes B.L. The filamentation pathway controlled by the Efg1 regulator protein is required for normal biofilm formation and development in Candida albicans. FEMS Microbiol Lett 2002, 214:95-100.
15. Stichternoth C., Ernst J.F. Hypoxic adaptation by Efg1 regulates biofilm formation by Candida albicans. Appl Environ Microbiol 2009, 75:3663-3672.
16. Lassak T., Schneider E., Bussmann M., Kurtz D., Manak J.R., Srikantha T., Soll D.R., Ernst J.F. Target specificity of the Candida albicans Efg1 regulator. Mol Microbiol 2011, 82:602-618.
17. Nobile C.J., Andes D.R., Nett J.E., Smith F.J., Yue F., Phan Q.T., Edwards J.E., Filler S.G., Mitchell A.P. Critical role of Bcr1-dependent adhesins in C. albicans biofilm formation in vitro and in vivo. PLoS Pathog 2006, 2:e63.
18. Fanning S., Xu W., Solis N., Woolford C.A., Filler S.G., Mitchell A.P. Divergent targets of Candida albicans biofilm regulator Bcr1 in vitro and in vivo. Eukaryot Cell 2012, 11:896-904.
19. Ding C., Butler G. Development of a gene knockout system in Candida parapsilosis reveals a conserved role for BCR1 in biofilm formation. Eukaryot Cell 2007, 6:1310-1319.
20. Nobile C.J., Fox E.P., Nett J.E., Sorrells T.R., Mitrovich Q.M., Hernday A.D., Tuch B.B., Andes D.R., Johnson A.D. A recently evolved transcriptional network controls biofilm development in Candida albicans. Cell 2012, 148:126-138.
21. Hnisz D., Bardet A.F., Nobile C.J., Petryshyn A., Glaser W., Schock U., Stark A., Kuchler K. A histone deacetylase adjusts transcription kinetics at coding sequences during Candida albicans morphogenesis. PLoS Genet 2012, 8:e1003118.
22. Finkel J.S., Xu W., Huang D., Hill E.M., Desai J.V., Woolford C.A., Nett J.E., Taff H., Norice C.T., Andes D.R., et al. Portrait of Candida albicans adherence regulators. PLoS Pathog 2012, 8:e1002525.
23. Ganguly S., Bishop A.C., Xu W., Ghosh S., Nickerson K.W., Lanni F., Patton-Vogt J., Mitchell A.P. Zap1 control of cell-cell signaling in Candida albicans biofilms. Eukaryot Cell 2011, 10:1448-1454.
24. Nobile C.J., Nett J.E., Hernday A.D., Homann O.R., Deneault J.S., Nantel A., Andes D.R., Johnson A.D., Mitchell A.P. Biofilm matrix regulation by Candida albicans Zap1. PLoS Biol 2009, 7:e1000133.
25. Kelly M.T., MacCallum D.M., Clancy S.D., Odds F.C., Brown A.J., Butler G. The Candida albicans CaACE2 gene affects morphogenesis, adherence and virulence. Mol Microbiol 2004, 53:969-983.
26. Gutierrez-Escribano P., Zeidler U., Suarez M.B., Bachellier-Bassi S., Clemente-Blanco A., Bonhomme J., Vazquez de Aldana C.R., d'Enfert C., Correa-Bordes J. The NDR/LATS kinase Cbk1 controls the activity of the transcriptional regulator Bcr1 during biofilm formation in Candida albicans. PLoS Pathog 2012, 8:e1002683.
27. Bharucha N., Chabrier-Rosello Y., Xu T., Johnson C., Sobczynski S., Song Q., Dobry C.J., Eckwahl M.J., Anderson C.P., Benjamin A.J., et al. A large-scale complex haploinsufficiency-based genetic interaction screen in Candida albicans: analysis of the RAM network during morphogenesis. PLoS Genet 2011, 7:e1002058.
28. Saputo S., Chabrier-Rosello Y., Luca F.C., Kumar A., Krysan D.J. The RAM network in pathogenic fungi. Eukaryot Cell 2012, 11:708-717.
29. Hawser S.P., Douglas L.J. Resistance of Candida albicans biofilms to antifungal agents in vitro. Antimicrob Agents Chemother 1995, 39:2128-2131.
30. Flemming H.C., Wingender J. The biofilm matrix. Nat Rev Microbiol 2010, 8:623-633.
31. Ramage G., VandeWalle K., Bachmann S.P., Wickes B.L., Lopez-Ribot J.L. In vitro pharmacodynamic properties of three antifungal agents against preformed Candida albicans biofilms determined by time-kill studies. Antimicrob Agents Chemother 2002, 46:3634-3636.
32. Baillie G.S., Douglas L.J. Matrix polymers of Candida biofilms and their possible role in biofilm resistance to antifungal agents. J Antimicrob Chemother 2000, 46:397-403.
33. Ramage G., Rajendran R., Sherry L., Williams C. Fungal biofilm resistance. Int J Microbiol 2012, 2012:528521.
34. Nett J., Lincoln L., Marchillo K., Andes D. Beta-1,3 glucan as a test for central venous catheter biofilm infection. J Infect Dis 2007, 195:1705-1712.
35. Nett J., Lincoln L., Marchillo K., Massey R., Holoyda K., Hoff B., VanHandel M., Andes D. Putative role of beta-1,3 glucans in Candida albicans biofilm resistance. Antimicrob Agents Chemother 2007, 51:510-520.
36. Vediyappan G., Rossignol T., d'Enfert C. Interaction of Candida albicans biofilms with antifungals: transcriptional response and binding of antifungals to beta-glucans. Antimicrob Agents Chemother 2010, 54:2096-2111.
37. Nett J.E., Crawford K., Marchillo K., Andes D.R. Role of Fks1p and matrix glucan in Candida albicans biofilm resistance to an echinocandin, pyrimidine, and polyene. Antimicrob Agents Chemother 2010, 54:3505-3508.
38. Nett J.E., Sanchez H., Cain M.T., Andes D.R. Genetic basis of Candida biofilm resistance due to drug-sequestering matrix glucan. J Infect Dis 2010, 202:171-175.
39. Taff H.T., Nett J.E., Zarnowski R., Ross K.M., Sanchez H., Cain M.T., Hamaker J., Mitchell A.P., Andes D.R. A Candida biofilm-induced pathway for matrix glucan delivery: implications for drug resistance. PLoS Pathog 2012, 8:e1002848.
40. Nett J.E., Sanchez H., Cain M.T., Ross K.M., Andes D.R. Interface of Candida albicans biofilm matrix-associated drug resistance and cell wall integrity regulation. Eukaryot Cell 2011, 10:1660-1669.
41. Stewart P.S., Franklin M.J. Physiological heterogeneity in biofilms. Nat Rev Microbiol 2008, 6:199-210.
42. Garcia-Sanchez S., Aubert S., Iraqui I., Janbon G., Ghigo J.M., d'Enfert C. Candida albicans biofilms: a developmental state associated with specific and stable gene expression patterns. Eukaryot Cell 2004, 3:536-545.
43. Gibbons J.G., Beauvais A., Beau R., McGary K.L., Latge J.P., Rokas A. Global transcriptome changes underlying colony growth in the opportunistic human pathogen Aspergillus fumigatus. Eukaryot Cell 2011, 11:68-78.
44. Murillo L.A., Newport G., Lan C.Y., Habelitz S., Dungan J., Agabian N.M. Genome-wide transcription profiling of the early phase of biofilm formation by Candida albicans. Eukaryot Cell 2005, 4:1562-1573.
45. Yeater K.M., Chandra J., Cheng G., Mukherjee P.K., Zhao X., Rodriguez-Zas S.L., Kwast K.E., Ghannoum M.A., Hoyer L.L. Temporal analysis of Candida albicans gene expression during biofilm development. Microbiology 2007, 153:2373-2385.
46. Nett J.E., Lepak A.J., Marchillo K., Andes D.R. Time course global gene expression analysis of an in vivo Candida biofilm. J Infect Dis 2009, 200:307-313.
47. Traven A., Janicke A., Harrison P., Swaminathan A., Seemann T., Beilharz T.H. Transcriptional profiling of a yeast colony provides new insight into the heterogeneity of multicellular fungal communities. PLoS ONE 2012, 7:e46243.
48. Cap M., Stepanek L., Harant K., Vachova L., Palkova Z. Cell differentiation within a yeast colony: metabolic and regulatory parallels with a tumor-affected organism. Mol Cell 2012, 46:436-448.
49. Petti A.A., McIsaac R.S., Ho-Shing O., Bussemaker H.J., Botstein D. Combinatorial control of diverse metabolic and physiological functions by transcriptional regulators of the yeast sulfur assimilation pathway. Mol Biol Cell 2012, 23:3008-3024.
50. Rossignol T., Ding C., Guida A., d'Enfert C., Higgins D.G., Butler G. Correlation between biofilm formation and the hypoxic response in Candida parapsilosis. Eukaryot Cell 2009, 8:550-559.
51. Askew C., Sellam A., Epp E., Hogues H., Mullick A., Nantel A., Whiteway M. Transcriptional regulation of carbohydrate metabolism in the human pathogen Candida albicans. PLoS Pathog 2009, 5:e1000612.
52. Bonhomme J., Chauvel M., Goyard S., Roux P., Rossignol T., d'Enfert C. Contribution of the glycolytic flux and hypoxia adaptation to efficient biofilm formation by Candida albicans. Mol Microbiol 2011, 80:995-1013.
53. LaFleur M.D., Kumamoto C.A., Lewis K. Candida albicans biofilms produce antifungal-tolerant persister cells. Antimicrob Agents Chemother 2006, 50:3839-3846.